Leading Cancer Charity Stops Funding Open Access Publishing Because It’s Just Not Working

from the publishers-mess-up-everything dept

As numerous posts on this blog have emphasised, the underlying idea of open access (OA) – allowing anyone to read and share published academic research for free – is great in principle, but in practice has failed in important ways. That’s because traditional academic publishers have subverted the open access model to such an extent that the costs for research institutions of publishing in OA journals have barely changed at all. And yet one of the other key aims of open access was to save money while widening availability. Against that background, a natural question to ask is: if open access has failed to deliver savings, why bother supporting it? Cancer Research UK, the world’s leading cancer charity, has evidently asked itself that question and come up with an answer, which it explains in a post entitled “Why we won’t be funding open access publishing any more”:

We need efficient scholarly communications to spread scientific ideas via a fair economic model. We currently don’t have that. The open access movement was bold and promising, but ultimately disappointing. Now is the time to stop and call for a new way to make publishing work…

…

Ceasing to fund open access in the way we currently do will save us £5.2m of donors’ money over the next three years. That’s a substantial amount which can be put towards cancer research.

The post by Dan Burkwood, Director of Research Operations and Communications at Cancer Research UK, explains what exactly the problem is:

We currently fund open access publishing for our researchers in a number of ways. Despite hopes that this would enable a flourishing of open access dissemination of science, most of the growth has occurred in hybrid journals. These are publications that combine OA articles with those behind a paywall – this means the publishers will still charge for university and institute libraries to access them, even though researchers have paid for their work to be published. For us, this means we currently use donated money to fund our researchers, institutes and centres to publish OA research articles, yet they still have to pay to access the majority of journals in which those articles appear. The publishers are – so to speak – having their cake whilst also eating it.

These so-called “hybrid models” are discussed at length in Chapter 3 of Walled Culture the book (free digital versions available). They were presented as a transitional approach towards journals that were fully open access, but in many cases that transition hasn’t happened, not least because the hybrid model is so profitable for publishers, who therefore have little incentive to move to fully open access titles. Burkwood rightly points to a key reason why academic publishers continue to wield such power: the academic world’s insistence on using published articles in prestigious titles as a metric of success.

Cancer Research UK are working to widen the way we evaluate research in order to mitigate the heavy focus on publication outputs. It’s clear to us that a broader view of an applicant’s career is vital to gauge potential success. By signing up to DORA (San Francisco Declaration on Research Assessment), we encourage our reviewers to assess the quality and impact of research through means other than just journal impact factor. Additionally, we invite applicants to submit a narrative CV, allowing a more holistic view of their track record, research outputs and career progression.

But as he acknowledges, “Despite our, and others, attempts to limit the emphasis of the ‘publish-or-perish’ mindset, it will take time for the culture to change.” In the meantime, he suggests:

If researchers have no access to publishing funds they can publish their work for open access at no cost, but the publication will sit behind a paywall for 6 months (under embargo) before being deposited on Europe PMC open access – this is known as green open access.

Green open access provides full and free access to papers, but only after an embargo period, typically six months, but sometimes longer (gold open access provides instant access, but requires payment by researchers’ institutions.) That makes green OA a poor substitute for real, immediate open access.

The problem here is that such embargo periods have long been accepted as the norm, but that is only because a terrible blunder was made over two decades ago by the Research Councils UK (RCUK). In 2005, the RCUK stipulated that the work it funded would require open access publication. However, when the final version of the RCUK’s policy appeared in June 2006, it had a significant flaw, expressed in the following provision: ‘Full implementation of these requirements must be undertaken such that current copyright and licensing policies, for example embargo periods or provisions limiting the use of deposited content to non-commercial purposes, are respected by authors.’ As the leading open access scholar Peter Suber wrote at the time, this was a completely unnecessary concession:

Researchers sign funding contracts with the research councils long before they sign copyright transfer agreements with publishers. Funders have a right to dictate terms, such as mandated open access, precisely because they are upstream from publishers. If one condition of the funding contract is that the grantee will deposit the peer-reviewed version of any resulting publication in an open-access repository [immediately], then publishers have no right to intervene.

At the root of the issue of embargoes lies copyright. If researchers retained full control of the copyright of their articles, rather than assigning it to publishers, they could prevent any embargoes being applied to them.

Cancer Research UK’s decision is regrettable but understandable. The fear has to be that others will follow suit. While the hybrid model is not universal, it is widespread enough to undermine the open access idea. Until researchers refuse to publish in such hybrid titles, publishers will continue to profit from them. Given the unnecessary embargoes imposed on articles released under green open access, that leaves alternatives such as diamond open access, where there are no charges for anyone, an approach that has long been espoused on this blog.

Follow me @glynmoody on Mastodon and on Bluesky. Originally posted to Walled Culture.

Filed Under: academic publishing, cancer research, copyright, hybrid, knowledge, open access, research

Companies: cancer research uk